Revance Therapeutics, Inc. reports

Company Names, identifiers, and filing context for this profile. 1 identity field
Company location
Nashville, TN
SEC filing record 1 source field available
Fiscal year end
31 December
Revance Therapeutics, Inc. has filed 947 SEC EDGAR filings since 23 Dec 2009

SEC filing history

Showing 551-575 of 946 matching filings.

Per page
25
Current page
23
4

FORM 4

Filing date
04 Jan 2019
Reporting date
03 Jan 2019
SEC evidence
Open document Open filing
Next action
Verify source filing
SC 13G/A File 005-88023

NONE

Filing date
04 Jan 2019
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
02 Jan 2019
Reporting date
31 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
17 Dec 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
14 Dec 2018
Reporting date
14 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
04 Dec 2018
Reporting date
04 Dec 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
21 Nov 2018
Reporting date
20 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
21 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
16 Nov 2018
Reporting date
15 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
09 Nov 2018
Reporting date
09 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
08 Nov 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
07 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
3

FORM 3

Filing date
07 Nov 2018
Reporting date
05 Nov 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
01 Nov 2018
Reporting date
29 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
17 Oct 2018
Reporting date
15 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
CORRESP

CORRESP filing

Filing date
15 Oct 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
11 Oct 2018
Reporting date
10 Oct 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
UPLOAD

UPLOAD filing

Filing date
13 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
CT ORDER File 001-36297

CT ORDER filing

Filing date
06 Sep 2018
Reporting date
Not listed
SEC evidence
Open document Open filing
Next action
Verify source filing
8-K File 001-36297

8-K

Filing date
02 Aug 2018
Reporting date
02 Aug 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
06 Jul 2018
Reporting date
06 Jul 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
4

FORM 4

Filing date
03 Jul 2018
Reporting date
29 Jun 2018
SEC evidence
Open document Open filing
Next action
Verify source filing
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .